Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 212.36 Million USD | -15.86% |
| 2022 | 252.39 Million USD | 9.14% |
| 2021 | 231.27 Million USD | 56.6% |
| 2020 | 147.68 Million USD | -18.73% |
| 2019 | 181.71 Million USD | 11.67% |
| 2018 | 162.72 Million USD | 7.41% |
| 2017 | 151.49 Million USD | 28.32% |
| 2016 | 118.05 Million USD | 24.58% |
| 2015 | 94.76 Million USD | 21.27% |
| 2014 | 78.13 Million USD | 4.75% |
| 2013 | 74.59 Million USD | -3.47% |
| 2012 | 77.27 Million USD | 28.18% |
| 2011 | 60.29 Million USD | 13.17% |
| 2010 | 53.27 Million USD | -0.76% |
| 2009 | 53.68 Million USD | -35.62% |
| 2008 | 83.37 Million USD | -18.04% |
| 2007 | 101.72 Million USD | 1.03% |
| 2006 | 100.69 Million USD | 33.16% |
| 2005 | 75.62 Million USD | 43.65% |
| 2004 | 52.64 Million USD | 34.67% |
| 2003 | 39.08 Million USD | 37.99% |
| 2002 | 28.32 Million USD | 46.56% |
| 2001 | 19.32 Million USD | 102.79% |
| 2000 | 9.53 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 38.79 Million USD | -21.69% |
| 2024 Q2 | 34.37 Million USD | -11.38% |
| 2023 FY | 212.36 Million USD | -15.86% |
| 2023 Q3 | 46.47 Million USD | -24.08% |
| 2023 Q1 | 54.99 Million USD | -18.35% |
| 2023 Q2 | 61.21 Million USD | 11.32% |
| 2023 Q4 | 49.54 Million USD | 6.59% |
| 2022 Q4 | 67.35 Million USD | 7.24% |
| 2022 FY | 252.39 Million USD | 9.14% |
| 2022 Q1 | 58.01 Million USD | -11.6% |
| 2022 Q2 | 64.22 Million USD | 10.7% |
| 2022 Q3 | 62.8 Million USD | -2.2% |
| 2021 Q1 | 49.66 Million USD | -0.55% |
| 2021 FY | 231.27 Million USD | 56.6% |
| 2021 Q3 | 57.38 Million USD | -2.06% |
| 2021 Q4 | 65.62 Million USD | 14.37% |
| 2021 Q2 | 58.58 Million USD | 17.96% |
| 2020 FY | 147.68 Million USD | -18.73% |
| 2020 Q1 | 32.23 Million USD | -37.76% |
| 2020 Q2 | 26.36 Million USD | -18.21% |
| 2020 Q4 | 49.94 Million USD | 27.63% |
| 2020 Q3 | 39.13 Million USD | 48.4% |
| 2019 Q2 | 47.77 Million USD | 32.61% |
| 2019 Q1 | 36.02 Million USD | -20.77% |
| 2019 Q4 | 51.79 Million USD | 12.31% |
| 2019 Q3 | 46.11 Million USD | -3.47% |
| 2019 FY | 181.71 Million USD | 11.67% |
| 2018 Q3 | 40.57 Million USD | -4.65% |
| 2018 Q1 | 34.12 Million USD | -28.36% |
| 2018 Q2 | 42.55 Million USD | 24.7% |
| 2018 FY | 162.72 Million USD | 7.41% |
| 2018 Q4 | 45.46 Million USD | 12.07% |
| 2017 Q2 | 36.38 Million USD | 24.2% |
| 2017 Q4 | 47.63 Million USD | 24.78% |
| 2017 Q3 | 38.17 Million USD | 4.9% |
| 2017 FY | 151.49 Million USD | 28.32% |
| 2017 Q1 | 29.29 Million USD | -22.64% |
| 2016 Q1 | 22.42 Million USD | -25.36% |
| 2016 Q2 | 27.47 Million USD | 22.54% |
| 2016 Q4 | 37.87 Million USD | 25.08% |
| 2016 Q3 | 30.28 Million USD | 10.2% |
| 2016 FY | 118.05 Million USD | 24.58% |
| 2015 Q4 | 30.04 Million USD | 30.14% |
| 2015 FY | 94.76 Million USD | 21.27% |
| 2015 Q3 | 23.08 Million USD | 2.31% |
| 2015 Q2 | 22.56 Million USD | 18.31% |
| 2015 Q1 | 19.07 Million USD | -25.21% |
| 2014 Q1 | 16.18 Million USD | -27.2% |
| 2014 Q2 | 17.72 Million USD | 9.48% |
| 2014 Q3 | 18.72 Million USD | 5.65% |
| 2014 Q4 | 25.49 Million USD | 36.17% |
| 2014 FY | 78.13 Million USD | 4.75% |
| 2013 Q1 | 15.96 Million USD | -29.14% |
| 2013 FY | 74.59 Million USD | -3.47% |
| 2013 Q4 | 22.23 Million USD | 32.15% |
| 2013 Q3 | 16.82 Million USD | -13.97% |
| 2013 Q2 | 19.56 Million USD | 22.5% |
| 2012 Q3 | 19.42 Million USD | -0.84% |
| 2012 FY | 77.27 Million USD | 28.18% |
| 2012 Q1 | 15.72 Million USD | -15.18% |
| 2012 Q2 | 19.59 Million USD | 24.57% |
| 2012 Q4 | 22.53 Million USD | 15.99% |
| 2011 Q3 | 15.23 Million USD | 2.26% |
| 2011 Q2 | 14.89 Million USD | 28.17% |
| 2011 Q1 | 11.62 Million USD | -23.63% |
| 2011 FY | 60.29 Million USD | 13.17% |
| 2011 Q4 | 18.54 Million USD | 21.73% |
| 2010 Q4 | 15.21 Million USD | 25.84% |
| 2010 FY | 53.27 Million USD | -0.76% |
| 2010 Q1 | 13.74 Million USD | -10.81% |
| 2010 Q2 | 12.21 Million USD | -11.14% |
| 2010 Q3 | 12.09 Million USD | -1.02% |
| 2009 Q1 | 14.43 Million USD | -19.37% |
| 2009 Q2 | 11.66 Million USD | -19.16% |
| 2009 Q4 | 15.41 Million USD | 26.66% |
| 2009 Q3 | 12.17 Million USD | 4.34% |
| 2009 FY | 53.68 Million USD | -35.62% |
| 2008 Q1 | 21.61 Million USD | -18.28% |
| 2008 Q3 | 19.11 Million USD | -22.8% |
| 2008 Q4 | 17.89 Million USD | -6.35% |
| 2008 FY | 83.37 Million USD | -18.04% |
| 2008 Q2 | 24.75 Million USD | 14.51% |
| 2007 Q3 | 28.14 Million USD | 17.89% |
| 2007 Q4 | 26.45 Million USD | -6.01% |
| 2007 FY | 101.72 Million USD | 1.03% |
| 2007 Q1 | 23.25 Million USD | -23.7% |
| 2007 Q2 | 23.87 Million USD | 2.65% |
| 2006 Q1 | 20.75 Million USD | -13.34% |
| 2006 Q4 | 30.48 Million USD | 21.64% |
| 2006 Q3 | 25.05 Million USD | 2.72% |
| 2006 Q2 | 24.39 Million USD | 17.53% |
| 2006 FY | 100.69 Million USD | 33.16% |
| 2005 FY | 75.62 Million USD | 43.65% |
| 2005 Q4 | 23.95 Million USD | 26.4% |
| 2005 Q3 | 18.95 Million USD | 7.85% |
| 2005 Q2 | 17.57 Million USD | 16.0% |
| 2005 Q1 | 15.14 Million USD | -5.88% |
| 2004 FY | 52.64 Million USD | 34.67% |
| 2004 Q3 | 12.7 Million USD | 3.57% |
| 2004 Q1 | 11.58 Million USD | -6.98% |
| 2004 Q2 | 12.26 Million USD | 5.92% |
| 2004 Q4 | 16.09 Million USD | 26.69% |
| 2003 Q4 | 12.44 Million USD | 12.92% |
| 2003 Q2 | 9.01 Million USD | 0.0% |
| 2003 FY | 39.08 Million USD | 37.99% |
| 2003 Q3 | 11.02 Million USD | 22.26% |
| 2002 FY | 28.32 Million USD | 46.56% |
| 2001 FY | 19.32 Million USD | 102.79% |
| 2000 FY | 9.53 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -1661.083% |
| BrainsWay Ltd. | 31.78 Million USD | -568.142% |
| Cerus Corporation | 156.36 Million USD | -35.814% |
| Envoy Medical, Inc. | 316 Thousand USD | -67105.38% |
| electroCore, Inc. | 16.03 Million USD | -1224.822% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -32876.553% |
| IceCure Medical Ltd | 3.22 Million USD | -6476.928% |
| Inogen, Inc. | 315.66 Million USD | 32.722% |
| OrthoPediatrics Corp. | 148.73 Million USD | -42.786% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -8646.664% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -58083.447% |
| MaxCyte, Inc. | 41.28 Million USD | -414.36% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -10777.102% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -191658.768% |
| Orthofix Medical Inc. | 746.64 Million USD | 71.557% |
| PAVmed Inc | 2.45 Million USD | -8561.052% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -843.066% |
| RxSight, Inc. | 89.07 Million USD | -138.411% |
| Sight Sciences, Inc. | 81.05 Million USD | -162.003% |
| SI-BONE, Inc. | 138.88 Million USD | -52.909% |
| TELA Bio, Inc. | 58.45 Million USD | -263.316% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -13.495% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -1438.794% |
| Acutus Medical, Inc. | 7.16 Million USD | -2864.391% |
| Talis Biomedical Corporation | 412 Thousand USD | -51445.874% |
| Spectral AI, Inc. | 18.05 Million USD | -1076.169% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -2044.059% |
| CVRx, Inc. | 39.29 Million USD | -440.448% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -21822.957% |
| Bioventus Inc. | 512.34 Million USD | 58.55% |
| Venus Concept Inc. | 76.35 Million USD | -178.137% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -1047.258% |
| LivaNova PLC | 1.15 Billion USD | 81.59% |
| 908 Devices Inc. | 50.22 Million USD | -322.802% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 55.964% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -275546.384% |
| NeuroPace, Inc. | 65.42 Million USD | -224.619% |
| LENSAR, Inc. | 42.16 Million USD | -403.674% |
| Apyx Medical Corporation | 52.34 Million USD | -305.679% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -536.636% |
| BioSig Technologies, Inc. | 18 Thousand USD | -1179727.778% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -27.425% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -786.533% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 86.224% |
| Axonics, Inc. | 366.37 Million USD | 42.036% |
| Outset Medical, Inc. | 130.37 Million USD | -62.89% |
| IRIDEX Corporation | 51.86 Million USD | -309.433% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -55.935% |
| IRadimed Corporation | 65.56 Million USD | -223.919% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -17958.588% |
| INVO Bioscience, Inc. | 3.02 Million USD | -6930.747% |
| Telesis Bio, Inc. | 27.5 Million USD | -671.998% |
| Viemed Healthcare, Inc. | 183 Million USD | -16.044% |
| Varex Imaging Corporation | 811 Million USD | 73.814% |
| Quipt Home Medical Corp. | 221.74 Million USD | 4.227% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -209.238% |
| Dynatronics Corporation | 32.53 Million USD | -552.761% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -2347.211% |
| Semler Scientific, Inc. | 68.18 Million USD | -211.465% |
| InMode Ltd. | 492.04 Million USD | 56.84% |
| Bruker Corporation | 2.96 Billion USD | 92.836% |
| Cytosorbents Corporation | 36.34 Million USD | -484.244% |
| DexCom, Inc. | 3.62 Billion USD | 94.137% |
| Align Technology, Inc. | 3.86 Billion USD | 94.501% |
| Viveve Medical, Inc. | 6.42 Million USD | -3204.84% |
| ZimVie Inc. | 457.43 Million USD | 53.574% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -10.027% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -191658.768% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 71.598% |
| Profound Medical Corp. | 7.33 Million USD | -2796.854% |
| Insulet Corporation | 1.69 Billion USD | 87.486% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -68.443% |
| iCAD, Inc. | 17.31 Million USD | -1126.291% |
| Nuwellis, Inc. | 8.86 Million USD | -2295.86% |
| Biotricity, Inc. | 12.06 Million USD | -1660.449% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 56.895% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -3322.546% |
| PAVmed Inc. | 2.45 Million USD | -8561.052% |
| BIOLASE, Inc. | 49.16 Million USD | -331.96% |
| Beyond Air, Inc. | 1.15 Million USD | -18223.469% |
| FONAR Corporation | 102.88 Million USD | -106.416% |
| AxoGen, Inc. | 159.01 Million USD | -33.555% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 22.613% |
| Inari Medical, Inc. | 493.63 Million USD | 56.978% |
| UFP Technologies, Inc. | 400.07 Million USD | 46.917% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -1141668.817% |
| Tenon Medical, Inc. | 2.92 Million USD | -7153.04% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -3017.555% |
| AdaptHealth Corp. | 3.2 Billion USD | 93.364% |
| Sintx Technologies, Inc. | 2.62 Million USD | -7984.088% |
| NanoVibronix, Inc. | 2.28 Million USD | -9202.19% |
| Quanterix Corporation | 122.36 Million USD | -73.549% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -770.186% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -5.909% |
| TransMedics Group, Inc. | 241.62 Million USD | 12.107% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -1432.907% |
| NeuroMetrix, Inc. | 5.9 Million USD | -3498.605% |
| Hyperfine, Inc. | 11.03 Million USD | -1825.027% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -28.591% |
| Biomerica, Inc. | 5.41 Million USD | -3821.865% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -320.025% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -19.892% |